BiondVax Pharma (BVXV) Reports Q1 Loss of NIS0.03/Share

BiondVax Pharma (NASDAQ: BVXV) reported Q1 EPS of (NIS0.03), versus (NIS0.04) reported last year.

For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance